Publication | Open Access
Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study
1.3K
Citations
40
References
2012
Year
OncologyMedicineUpdated ResultsPathologyBronchial NeoplasmMolecular OncologyAnti-cancer AgentCancer TreatmentPharmacologyRadiation OncologyPhase 1Lung CancerCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1